p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 501–600 of 1,000
Guo, J., Huang, Y., Bian, S., Zhao, C., Jin, Y., Yu, D., Wu, X., Zhang, D., Cao, W., Jing, F., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.04.108 · Cited by 66
Clock genes, hair growth and aging
Geyfman, M., & Andersen, B. (2010) · Aging · doi:10.18632/aging.100130 · Cited by 72
“Several mouse models with premature aging phenotypes show progressive hair loss or graying [36-38], and human conditions with progeria-like symptoms, such as Werner Syndrome and Hutchinson-Gilford Progeria, present with premature hair loss or hair graying [39].”
BackgroundLin28 and let-7 in the Metabolic Physiology of Aging
Jun‐Hao, E. T., Gupta, R., & Shyh‐Chang, N. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.12.006 · Cited by 67
p16 and ARF: activation of teenage proteins in old age
Satyanarayana, A., & Rudolph, K. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423437 · Cited by 64
Andersen, S. L., Terry, D. F., Wilcox, M., Babineau, T. J., Malek, K. S., & Perls, T. T. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.019 · Cited by 65
“A hyperactive mutation of p53 leads to a decrease in tumorogenesis; however, the same mice also develop some premature aging phenotypes as well as a shortened lifespan (Tyner et al., 2002).”
BackgroundUrodele p53 tolerates amino acid changes found in p53 variants linked to human cancer
Villiard, É., Brinkmann, H., Moiseeva, O. V., Mallette, F. A., Ferbeyre, G., & Roy, S. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-180 · Cited by 67
“The longevity factor is also of importance considering the ability of p53 to promote aging in mice even while increasing cancer protection [9].”
BackgroundPerls, T. T., Kunkel, L. M., & Puca, A. A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00310-6 · Cited by 73
Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways
Chen, Z., Yi, W., Morita, Y., Wang, H., Cong, Y., Liu, J., Xiao, Z., Rudolph, K. L., Cheng, T., & Ju, Z. (2015) · Nature Communications · doi:10.1038/ncomms7808 · Cited by 68
Dachshund Binds p53 to Block the Growth of Lung Adenocarcinoma Cells
Chen, K., Wu, K., Cai, S., Zhang, W., Zhou, J., Wang, J., Ertel, A., Li, Z., Rui, H., Quong, A. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3191 · Cited by 64
“The diminished stem cell function observed in certain strains of mice encoding germ line alleles of mutant p53 (the gene encoding p53, also known as Trp53) (33, 34), and the diminished stem cell pool in Dach1 mice (27), is consistent with the possibility that DACH1 and p53 may also cooperate in stem cell function.”
Extension of mouse lifespan by overexpression of catalase
Schriner, S. E., & Linford, N. J. (2006) · AGE · doi:10.1007/s11357-006-9010-z · Cited by 67
“1999), while some age-accelerated models appear to mediate their phenotypes through increased apoptosis (Trifunovic et al. 2004; Tyner et al. 2002).”
BackgroundNegative Regulation of p53 Functions by Daxx and the Involvement of MDM2
Zhao, L., Liu, J., Sidhu, G. S., Niu, Y., Liu, Y., Wang, R., & Liao, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406743200 · Cited by 63
The price of tumour suppression?
Ferbeyre, G., & Lowe, S. W. (2002) · Nature · doi:10.1038/415026a · Cited by 80
The DNA damage response: balancing the scale between cancer and ageing.
Seviour, E. G., & Lin, S.-Y. (2010) · Aging · doi:10.18632/aging.100248 · Cited by 61
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Wang, M., & Attardi, L. D. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-025840 · Cited by 67
Cellular senescence: unravelling complexity
Passos, J. F., Simillion, C., Hallinan, J. S., Wipat, A., & von Zglinicki, T. (2009) · AGE · doi:10.1007/s11357-009-9108-1 · Cited by 71
“Genetic activation of p53 shortened mice lifespan despite suppression of tumour formation (Maier et al. 2004; Tyner et al. 2002), while a p21 knock-out rescued at least some accelerated aging phenotypes in telomerase (mTERC) knock-out mice (Choudhury et al. 2007), and p16 knockout rescued various…”
BackgroundWarner, H. R. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.7.b692 · Cited by 68
A new hypothesis for the cancer mechanism
Meng, X., Zhong, J., Liu, S., Murray, M. M., & Gonzalez-Angulo, A. M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9342-8 · Cited by 74
CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination
Latini, P., Frontini, M., Caputo, M., Gregan, J., Cipak, L., Filippi, S., Kumar, V., Vélez-Cruz, R., Stefanini, M., & Proietti-De-Santis, L. (2011) · Cell Cycle · doi:10.4161/cc.10.21.17905 · Cited by 60
Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
Guo, S. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12221 · Cited by 60
Roles of Apoptosis and Cellular Senescence in Cancer and Aging
Cerella, C., Grandjenette, C., Dicato, M. A., & Diederich, M. F. (2016) · Current Drug Targets · doi:10.2174/1389450116666150202155915 · Cited by 71
Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNA
Eller, M. S., Li, G., Firoozabadi, R., Puri, N., & Gilchrest, B. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0197com · Cited by 60
“Equally, the phenomenon suggests that the advantages of robust DNA damage responses of the type observed in p53 overexpressing mice can be separated from the premature senescence also observed in these transgenic animals ( 71 ).”
BackgroundAging and Longevity: The IGF-1 Enigma
Anversa, P. (2005) · Circulation Research · doi:10.1161/01.res.0000182212.09147.56 · Cited by 67
The Scoliosis Quandary: Are Radiation Exposures From Repeated X-Rays Harmful?
Oakley, P. A., Ehsani, N. N., & Harrison, D. E. (2019) · Dose-Response · doi:10.1177/1559325819852810 · Cited by 67
Hou, X., Wei, Z., Zouboulis, C. C., & Ju, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.909694 · Cited by 71
“It has been demonstrated in several studies that the activation of p53 results in accelerated aging phenotypes in mice models (Tyner et al., 2002; Maier et al., 2004; Gannon et al., 2011), showing slow hair follicle cycling, epidermis thinning, reduced wound healing, and reduction of subcutaneous adipose lipid.”
BackgroundReduced Life- and Healthspan in Mice Carrying a Mono-Allelic BubR1 MVA Mutation
Wijshake, T., Malureanu, L. A., Baker, D. J., Jeganathan, K. B., van de Sluis, B., & van Deursen, J. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003138 · Cited by 59
Haustead, D. J., Stevenson, A., Saxena, V., Marriage, F., Firth, M., Silla, R., Martin, L., Adcroft, K. F., Rea, S., Day, P. J., et al. (2016) · Scientific Reports · doi:10.1038/srep26846 · Cited by 59
Multiple facets of p53 in senescence induction and maintenance
Johmura, Y., & Nakanishi, M. (2016) · Cancer Science · doi:10.1111/cas.13060 · Cited by 59
Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary Epithelium
Gross, K. M., Zhou, W., Breindel, J. L., Ouyang, J., Jin, D. X., Sokol, E. S., Gupta, P. B., Huber, K., Zou, L., & Kuperwasser, C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.043 · Cited by 58
Ménendez, S., Camus, S., Herreria, A., Paramonov, I., Batlle‐Morera, L., Collado, M., Pekařík, V., Maceda, I., Edel, M. J., Consiglio, A., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00754.x · Cited by 58
“The constitutive activation of p53, in fact, has been linked to a premature aging phenotype (Tyner et al., 2002).”
BackgroundThe Bcl-2 protein family and its role in the development of neoplastic disease
Heiser, D., Labi, V., Erlacher, M., & Villunger, A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.011 · Cited by 64
Cellular signaling in normal and cancerous stem cells
Grinstein, E., & Wernet, P. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.06.021 · Cited by 61
The yin and yang of the Cdkn2a locus in senescence and aging
Baker, D. J., Jin, F., & van Deursen, J. M. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6687 · Cited by 56
Agephagy – Adapting Autophagy for Health During Aging
Stead, E. R., Castillo-Quan, J. I., Martinez-Miguel, V. E., Lujan, C., Ketteler, R., Kinghorn, K. J., & Bjedov, I. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00308 · Cited by 62
“Overexpression of AMPK in the Drosophila nervous system induces autophagy in the brain and cell non-autonomously in the intestine, resulting in lifespan extension (Ulgherait et al., 2014).”
BackgroundAging and age-related diseases – From endocrine therapy to target therapy
Bao, Q., Pan, J., Qi, H., Wang, L., Qian, H., Jiang, F., Shao, Z., Xu, F., Tao, Z., Ma, Q., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.005 · Cited by 63
Chen, C., Abell, A. M., Moon, Y. S., & Kim, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399790 · Cited by 66
“The lipids accumulated in differentiated preadipocytes at day 8 were stained with Oil Red O (ORO) as described previously (22, 23).”
BackgroundMethodp53 induces skin aging by depleting Blimp1+ sebaceous gland cells
Kim, J., Nakasaki, M., Todorova, D., Lake, B., Yuan, C.-Y., Jamora, C., & Xu, Y. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.87 · Cited by 55
“However, this morphology differs from aged skin that additionally becomes thinner in the dermis,(3) a phenotype already reported for p53-mediated accelerated aging by the same group.(4) These results suggest that skin aging phenotypes arise from defects in multiple cell types and not simply the epidermal derivatives.”
BackgroundResultBalancing DNA repair to prevent ageing and cancer
Stead, E. R., & Bjedov, I. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112679 · Cited by 73
“The clearance of 376 senescent cells extends lifespan and delays the onset of cancer (Baker, Wijshake et al. 2011, Muñoz-377 Espín and Serrano 2014, van Deursen 2014, Baker, Childs et al. 2016, Chang, Wang et al. 2016, 378 Roos, Zhang et al. 2016, McHugh and Gil 2018).”
BackgroundLei, H., Cao, H., Chen, X., Su, Z., Deng, S., Hu, Y., Wu, L., Gui, X., Gao, C., Jia, X., et al. (2025) · Advanced Materials · doi:10.1002/adma.202413238 · Cited by 68
Liao, C., & Kennedy, B. K. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00003-2 · Cited by 62
“…resulted in a resistance to spontaneous tumors compared to wild-type littermates, but surprisingly exhibited early aging-related phenotypes, such as muscle and lymphoid atro- phy, osteoporosis, a reduced subcutaneous adipose and dermal thickness, and shorter lifespan (Tyner et al., 2002).”
Backgroundp53 as an intervention target for cancer and aging
Hasty, P., & Christy, B. A. (2013) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v3i0.22702 · Cited by 56
“reduced cancer but accelerated aging in mice (45,46).”
BackgroundAging as a substrate of heart failure
Shioi, T., & Inuzuka, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.07.015 · Cited by 71
Δ40 Isoform of p53 Controls β-Cell Proliferation and Glucose Homeostasis in Mice
Hinault, C., Kawamori, D., Liew, C. W., Maier, B., Hu, J., Keller, S. R., Mirmira, R. G., Scrable, H. J., & Kulkarni, R. (2011) · Diabetes · doi:10.2337/db09-1379 · Cited by 58
“Expression of ectopic D40p53 in the mouse alters the balance between the full-length and short isoforms that normally exists and hyperactivates p53 (22,36,38).”
BackgroundMutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
Ferraiuolo, M. A., Verduci, L., Blandino, G., & Strano, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050961 · Cited by 56
“Mice models overexpressing wild-type p53 protein or p53 heterozygous mutants show reduced susceptibility to tumor formation and reduced lifespan [60,61] associated with premature aging [59,62].”
BackgroundMajeed, N., Blouin, M., Kaplan‐Lefko, P. J., Barry-Shaw, J., Greenberg, N. M., Gaudreau, P., Bismar, T. A., & Pollak, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208572 · Cited by 57
“Both are associated with substantial reduction in tumor incidence, but the former leads to enhanced longevity (Flurkey et al., 2001) while animals with the latter mutation display an accelerated aging phenotype (Tyner et al., 2002).”
BackgroundChaturvedi, V., Qin, J. ‐., Stennett, L., Choubey, D., & Nickoloff, B. J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10392 · Cited by 56
Using Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Donehower, L. A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001081 · Cited by 55
“However, the p53þ/m mice had a 23% shortened longevity compared with wild-type littermates and displayed a number of accelerated aging phenotypes, including organ atrophy, osteoporosis, skin atrophy, and reduced tolerance to stresses (Tyner et al. 2002).”
BackgroundInfluentialSelf-citationActions of 17β-estradiol and testosterone in the mitochondria and their implications in aging
Vasconsuelo, A., Milanesi, L., & Boland, R. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.001 · Cited by 55
“In connection with p66shc, the phosphorylation of the p53 tumor suppressor is also associated with aging (Tyner et al., 2002).”
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 69
Glycolysis links p53 function with NF‐κB signaling: Impact on cancer and aging process
Salminen, A., & Kaarniranta, K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22119 · Cited by 55
“Tyner et al. (2002) generated a p53 transgenic mouse which expresses one full-length p53 allele and one truncated allele capable of encoding a carboxy-terminal p53 fragment.”
BackgroundPinto, M., Pickrell, A. M., Wang, X., Bacman, S. R., Yu, A., Hida, A., Dillon, L. M., Morton, P. D., Malek, T. R., Williams, S. L., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.123 · Cited by 61
Increased transport of acetyl‐CoA into the endoplasmic reticulum causes a progeria‐like phenotype
Peng, Y., Shapiro, S. L., Banduseela, V. C., Dieterich, I. A., Hewitt, K. J., Bresnick, E. H., Kong, G., Zhang, J., Schueler, K. L., Keller, M. P., et al. (2018) · Aging Cell · doi:10.1111/acel.12820 · Cited by 54
“In the case of p53/p44, the primary defect is in the N‐terminal regulatory functions of the p53 protein, which leads to reduced stemness potential of stem cells as well as hyperactivation of IGF‐1R signaling (Campisi, 2004; Lessel et al., 2017; Maier et al., 2004; Pehar, Ko, Li, Scrable, & Puglielli, 2014; Tyner et al…”
Vazquez, J. M., & Lynch, V. J. (2021) · eLife · doi:10.7554/elife.65041 · Cited by 61
Open-minded scepticism: inferring the causal mechanisms of human ageing from genetic perturbations
de Magalhães, J. P. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2004.05.003 · Cited by 54
“, 2003), p53 (Donehower, 2002; Tyner et al., 2002), and Ercc1 (Weeda et al.”
Mutant mice with small amounts of BubR1 display accelerated age-related gliosis
Hartman, T. K., Wengenack, T. M., Poduslo, J. F., & van Deursen, J. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.012 · Cited by 54
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Fernández Rodríguez, R., Finnerty, P. M., Ruoff, R., Bardeesy, N., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 54
Metabolic homeostasis and tissue renewal are dependent on β1,6GlcNAc-branched N-glycans
Cheung, P., Pawling, J., Partridge, E. A., Sukhu, B., Grynpas, M., & Dennis, J. W. (2007) · Glycobiology · doi:10.1093/glycob/cwm048 · Cited by 54
“Increased p53 activity also suppresses tumor development, and favors arrest signaling, oxidative metabolism, loss of stem cells, and early mortality (Tyner et al. 2002; van Heemst et al. 2005), features common with the Mgat5 phenotype.”
BackgroundConditional over-expression of PITX1 causes skeletal muscle dystrophy in mice
Pandey, S. N., Cabotage, J., Shi, R., Dixit, M., Sutherland, M., Liu, J., Muger, S., Harper, S. Q., Nagaraju, K., & Chen, Y. (2012) · Biology Open · doi:10.1242/bio.20121305 · Cited by 60
“mice are more resistant to cancer (Tyner et al., 2002).”
Yabumoto, C., Akazawa, H., Yamamoto, R., Yano, M., Kudo-Sakamoto, Y., Sumida, T., Kamo, T., Yagi, H., Shimizu, Y., Saga-Kamo, A., et al. (2015) · Scientific Reports · doi:10.1038/srep14453 · Cited by 54
A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
Zhao, Y., Wu, L., Yue, X., Zhang, C., Wang, J., Li, J., Sun, X., Zhu, Y., Feng, Z., & Hu, W. (2018) · eLife · doi:10.7554/elife.34701 · Cited by 57
Lessons from p53 in non-mammalian models
Lu, W.-J., & Abrams, J. M. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401922 · Cited by 42
Danilova, N., Sakamoto, K. M., & Lin, S. (2008) · Mechanisms of Development · doi:10.1016/j.mod.2008.09.003 · Cited by 65
Wang, Y. V., Leblanc, M., Fox, N., Mao, J.-H., Tinkum, K. L., Krummel, K., Engle, D., Piwnica-Worms, D., Piwnica-Worms, H., Balmain, A., et al. (2011) · Genes & Development · doi:10.1101/gad.2024411 · Cited by 53
“Wild-type (WT) and p537KR mutant mice have similar life spans We first asked whether p537KR elicits a premature aging phenotype, as reported previously for some mouse mutants with elevated p53 activity (e.g., see Garcı́a-Cao et al. 2002; Tyner et al. 2002).”
BackgroundRelationships between stem cell exhaustion, tumour suppression and ageing
Ruzankina, Y., & Brown, E. J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604029 · Cited by 53
“%) in comparison to wild-type control mice (45%), although this incidence may be underrepresented due to decreased longevity (Tyner et al, 2002).”
BackgroundResultHafsi, H., & Hainaut, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3771 · Cited by 53
Aging: gene silencing or gene activation?
Burzynski, S. R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.010 · Cited by 62
“This was contradicted by other researchers who found that dwarfs in p44 and p53 experiments lived a short period of time [26,31–33].”
BackgroundResultBasal p53 expression is indispensable for mesenchymal stem cell integrity
Boregowda, S. V., Krishnappa, V., Strivelli, J., Haga, C. L., Booker, C. N., & Phinney, D. G. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0004-4 · Cited by 60
“Moreover, since it is well established that p53 loss-offunction has anti-aging effects [1] and p53-activating mutations cause early-onset aging-associated phenotypes in mice [41], our findings have important implications with respect to the role of MSCs in aging.”
BackgroundPenson, R. T., Daniels, K. J., & Lynch, T. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-3-343 · Cited by 56
“Mice engineered to upregulate activity of the p53 tumor-suppressor gene have a lower incidence of cancer development [ 34 , 35].”
BackgroundSIRT1 signaling pathways in sarcopenia: Novel mechanisms and potential therapeutic targets
Yang, L., Liu, D., Jiang, S., Li, H., Chen, L., Wu, Y., Essien, A. E., Opoku, M., Naranmandakh, S., Liu, S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116917 · Cited by 67
dSir2 and longevity in Drosophila
Frankel, S. A., Ziafazeli, T., & Rogina, B. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.007 · Cited by 59
“Mice with hyperactivated p53 show signs of a premature aging phenotype marked by osteoporosis, decreased stress resistance and organ atrophy (Tyner et al., 2002).”
Stem cell aging: Survival of the laziest?
Muller-Sieburg, C., & Sieburg, H. B. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7214 · Cited by 52
Increased Arf/p53 activity in stem cells, aging and cancer
Carrasco‐García, E., Moreno, M., Moreno‐Cugnon, L., & Matheu, A. (2017) · Aging Cell · doi:10.1111/acel.12574 · Cited by 54
“osteoporosis and early and intense loss of cellularity and tissue mass (Tyner et al., 2002), reflecting defects in organ homeostasis.”
BackgroundInfluentialEvolution of cancer suppression as revealed by mammalian comparative genomics
Tollis, M., Schiffman, J. D., & Boddy, A. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.12.004 · Cited by 62
Liu, Z., Jin, L., Yang, J.-K., Wang, B., Wu, K. K. L., Hallenborg, P., Xu, A., & Cheng, K. K. Y. (2018) · Diabetes · doi:10.2337/db18-0684 · Cited by 52
“Expression of the active form of p53, which lacks of MDM2-binding domain, reduces life span (9).”
BackgroundPilot screening programme for small molecule activators of p53
Berkson, R. G., Hollick, J. J., Westwood, N. J., Woods, J. A., Lane, D. P., & Lain, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.20968 · Cited by 52
“Induction of the p53 response in normal tissues is thought to be responsible for some of the adverse side effects of many current chemotherapeutic drugs, and a constitutive increase in p53 activity is associated with premature ageing in mice.(16) A more encouraging observation is that mice with an extra copy of the p5…”
BackgroundSIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53
Lynch, C. J., Shah, Z. H., Allison, S. J., Ahmed, S. U., Ford, J. R., Warnock, L. J., Li, H., Serrano, M., & Milner, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013502 · Cited by 57
The Effects of Cobalt on the Development, Oxidative Stress, and Apoptosis in Zebrafish Embryos
Cai, G., Zhu, J., Shen, C., Cui, Y., Du, J., & Chen, X. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9506-6 · Cited by 51
“The tumor suppressor p53, a nuclear transcription factor, can induce pro-apoptotic genes or suppress anti-apoptotic genes in response to DNA damage or irreparable cell cycle arrest [35].”
BackgroundIGF-I enhances cellular senescence via the reactive oxygen species–p53 pathway
Handayaningsih, A. E., Takahashi, M., Fukuoka, H., Iguchi, G., Nishizawa, H., Yamamoto, M., Suda, K., & Takahashi, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.140 · Cited by 58
Choi, E. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.01.038 · Cited by 52
“Furthermore, osteoporosis has recently been noted in two mouse models of premature aging associated with oxidative damage (Tyner et al., 2002).”
BackgroundMurine Models of Life Span Extension
Quarrie, J. K., & Riabowol, K. T. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.31.re5 · Cited by 51
Stem Cells Use Distinct Self-renewal Programs at Different Ages
Levi, B. P., & Morrison, S. J. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.049 · Cited by 59
“Overexpression of short isoforms of p53 in mice leads to early-onset aging phenotypes and decreased longevity (Tyner et al. 2002; Maier et al. 2004).”
BackgroundA functional single nucleotide polymorphism in promoter of ATM is associated with longevity
Chen, T., Dong, B., Lu, Z., Tian, B., Zhang, J., Zhou, J., Wu, H., Zhang, Y., Wu, J., & Lin, P. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.08.009 · Cited by 49
“Thus, moderate activity of genes may keep subjects from abnormal physiological function (Tyner et al., 2002).”
BackgroundJing, H., Anderson, L., Sturre, M. J. G., Hille, J., & Dijkwel, P. P. (2007) · Journal of Experimental Botany · doi:10.1093/jxb/erm237 · Cited by 52
“developed fewer tumours than wild-type (p53+l+) homo The reduced growth and development of adult cpr5 plants zygotes, but exhibited faster ageing (Tyner et al., 2002).”
BackgroundModified aging of elite athletes revealed by analysis of epigenetic age markers
Spólnicka, M., Pośpiech, E., Adamczyk, J. G., Freire-Aradas, A., Pepłońska, B., Zbieć-Piekarska, R., Makowska, Ż., Pięta, A., Lareu, M. V., Phillips, C., et al. (2018) · Aging · doi:10.18632/aging.101385 · Cited by 57
“Interestingly, a study of mutants in the p53 tumor suppressor gene has shown that increased tumor protection occurs from modified p53 protein, while at the same time these induce early onset aging in mice; linking senescence, aging and cancer [37].”
BackgroundAging and cancer cell biology, 2008
Campisi, J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00383.x · Cited by 50
Understanding and Modulating Ageing
Rattan, S. I. S., & Clark, B. F. C. (2005) · IUBMB Life · doi:10.1080/15216540500092195 · Cited by 64
“In contrast, reduced activity of the tumour suppressor defense gene p53 induces premature ageing in mice ( 45 ).”
BackgroundRegulation of p53 during senescence in normal human keratinocytes
Kim, R. H., Kang, M., Kim, T., Yang, P., Bae, S., Williams, D. W., Phung, S., Shin, K., Hong, C., & Park, N. (2015) · Aging Cell · doi:10.1111/acel.12364 · Cited by 54
“For example, in transgenic mouse models, augmenting the endogenous p53 activity with a truncated form of p53 or an extra copy of wildtype, full-length p53 transgene enhanced resistance to spontaneous tumor development (Garc ıa-Cao et al., 2002; Tyner et al., 2002).”
BackgroundFrom tissue turnover to the cell of origin for pancreatic cancer
Kong, B., Michalski, C. W., Erkan, M., Friess, H., & Kleeff, J. H. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.114 · Cited by 59
Effect of stem cell turnover rates on protection against cancer and aging
Wodarz, D. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.10.013 · Cited by 47
Xu, P., & Davis, R. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00795-09 · Cited by 53
“This is because altered p53 function is established to be an important determinant of early aging (36, 55).”
BackgroundVatner, D. E., Zhang, J., Oydanich, M. K., Guers, J. J., Katsyuba, E., Yan, L., Sinclair, D. A., Auwerx, J. H., & Vatner, S. F. (2018) · Aging Cell · doi:10.1111/acel.12751 · Cited by 50
p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation
Yoon, M.-H., Kang, S., Lee, S. J., Woo, T., Oh, A.-Y., Park, S., Ha, N., & Park, B.-J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1378-7 · Cited by 55
Dermal Drivers of Injury-Induced Inflammation: Contribution of Adipocytes and Fibroblasts
Cooper, P. O., Haas, M. R., Noonepalle, S. K. R., & Shook, B. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041933 · Cited by 71
“Nevertheless, when gender, hair cycle, and location are accounted for, aged murine DWAT decreases in prominence [207,208] and differentiation potential [209].”
Backgroundα- and γ-Tocopherol Prevent Age-Related Transcriptional Alterations in the Heart and Brain of Mice3
Park, S.-K., Page, G. P., Kim, K., Allison, D. B., Meydani, M., Weindruch, R. H., & Prolla, T. A. (2008) · Journal of Nutrition · doi:10.1093/jn/138.6.1010 · Cited by 57
Shukla, V., Coumoul, X., Cao, L., Wang, R.-H., Xiao, C., Xu, X., Andò, S., Yakar, S., LeRoith, D., & Deng, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4570 · Cited by 49
“These observations are consistent with recent findings that p53activation plays an important role in aging process ( 9 , 10).”
New approaches for modelling cancer mechanisms in the mouse
Maddison, K., & Clarke, A. R. (2005) · The Journal of Pathology · doi:10.1002/path.1698 · Cited by 61
“In this light, it is intriguing that mice with a deletion of the first six exons of p53 , which encodes a truncated RNA forming a carboxy-terminal p53 fragment, have been shown to have an altered lifespan [102].”
BackgroundApoptosis and tumor resistance conferred by Par-4
Zhao, Y., & Rangnekar, V. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.6945 · Cited by 53
Irminger‐Finger, I. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8928 · Cited by 51
Bradley, S. V., Hyun, T. S., Oravecz-Wilson, K. I., Li, L., Waldorff, E. I., Ermilov, A. N., Goldstein, S. A., Zhang, C. X., Drubin, D. G., Varela, K., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm076 · Cited by 48
Cui, R., Nguyen, T. T. T., Taube, J. H., Stratton, S. A., Feuerman, M. H., & Barton, M. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504655200 · Cited by 51
Chen, H., Hu, X., Yang, R., Wu, G., Tan, Q., Goltzman, D., & Miao, D. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48169 · Cited by 54
“Oxidative stress levels of osteon structures are increased with age [37] and mouse models of osteoporosis are usually accompanied by increased oxidative stress [38, 39].”
Background
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.